Sanofi has appointed Lisa Sha as General Manager for Vaccines in the UK and Ireland. The move comes as the company strengthens its commitment to public health and prepares for the next phase of growth and innovation.
Lisa joined Sanofi in 2019 and has held leadership roles across Europe and the US. Most recently, she served as Franchise Head of the Established Portfolio in the UK and Ireland, where she revitalised operations and culture across multiple therapy areas.
Her previous contributions include leading cardiovascular therapy launches in Northern Europe and supporting strategic initiatives such as the Customer First Operating Model and transplant therapy planning in the EU.
Karine Labaky, Head of Key Markets, Vaccines, said: “I am delighted to welcome Lisa to this critical role. Lisa’s appointment comes at an important time as we look to further strengthen our commitment to public health, working alongside healthcare partners and stakeholders.
“Lisa’s strategic mindset and dynamic leadership approach will be invaluable as we advance our vaccines mission in the UK and Ireland. Her proven ability to drive transformation and build high-performing teams makes her ideally placed to lead our vaccines organisation into its next chapter of growth and innovation.”
Lisa said: “As someone who has seen the transformative power of vaccines first-hand, I am deeply honoured to take on this role at such a crucial time for public health in the UK and Ireland. Vaccines are more than just medicine – they are the foundation of healthy communities.”
